(Q40711577)

23 September 2017

In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV. (English)

1 reference

23 September 2017

0 references

Carr A

1

1 reference

23 September 2017

Tindall B

series ordinal

2

1 reference

23 September 2017

Penny R

series ordinal

3

1 reference

23 September 2017

Cooper DA

series ordinal

4

1 reference

23 September 2017

1 October 1993

1 reference

Clinical and Experimental Immunology

23 September 2017

1 reference

23 September 2017

94

1 reference

23 September 2017

1

1 reference

23 September 2017

21-25

1 reference

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

23 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1993.TB05971.X

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1993.TB05971.X

Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1993.TB05971.X

Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1993.TB05971.X

Trimethoprim-Sulfamethoxazole Treatment ofPneumocystis cariniiPneumonia in Adults

21 January 2018

1 reference

12 December 2020

Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.

1 reference

12 December 2020

Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients

1 reference

12 December 2020

A coordinated approach to children's health in India: progress report after five years (1975-1980)

1 reference

12 December 2020

Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma

1 reference

12 December 2020

Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial

1 reference

12 December 2020

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

1 reference

12 December 2020

Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.

1 reference

12 December 2020

Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites

1 reference

12 December 2020

Rash with amoxycillin-clavulanate therapy in HIV-infected patients

1 reference

12 December 2020

Systemic glutathione deficiency in symptom-free HIV-seropositive individuals

1 reference

12 December 2020

Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease

1 reference

12 December 2020

Allergic manifestations of human immunodeficiency virus (HIV) infection

1 reference

12 December 2020

Adverse reactions to co-trimoxazole in HIV infection

1 reference

12 December 2020

Glutathione deficiency and human immunodeficiency virus infection

1 reference

12 December 2020

Comparison of pentamidine isethionate andtrimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

10.1111/J.1365-2249.1993.TB05971.X

Identifiers

DOI

1 reference

23 September 2017

1 reference